Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract LB342: Potent Anti-Tumor Activity Demonstrated by Anti-AXL CAR T Cell Therapy and AXL-ADC in Lung Cancer and Breast Cancer Models

Zhongen Wu, Yang Gao, Jingpeng Pei, Enfeng Zhao, Shenglin Mei, Yuxiong Feng, Di Zhu

Cancer Res (2024) 84 (7_Supplement): LB342.

https://doi.org/10.1158/1538-7445.AM2024-LB342

Published: 05 April 2024

View articletitled, Abstract LB342: Potent Anti-Tumor Activity Demonstrated by Anti-AXL CAR T Cell Therapy and AXL-ADC in Lung Cancer and Breast Cancer Models

Journal Articles

Abstract 3225: Profiling the DNA regulome to discover direct inhibitors of the brachyury transcription factor

Alexander Joel Federation, Yang Gao, Brian McEllin, Tonibelle Gatbonton-Schwager, Andrea Gutierrez, Julia Robbins, Bodhi Hueffmeier, Erin Broderick, Daniele Canzani, William Fondrie, Lindsay Pino

Cancer Res (2024) 84 (6_Supplement): 3225.

https://doi.org/10.1158/1538-7445.AM2024-3225

Published: 22 March 2024

View articletitled, Abstract 3225: Profiling the DNA regulome to discover direct inhibitors of the brachyury transcription factor

Journal Articles

Abstract 3426: Catalytic degraders effectively address kinase site mutations in EML-ALK oncogenic fusions

Yang Gao, Baishan Jiang, Hellen Kim, Jianwei Che, Katherine Donovan, John Hatcher, Fidel Huerta, Nicholas Kwiatkowski, Yingpeng Liu, Peter Liuni, Rebecca J. Metivier, Vineeth Murali, Radosław Nowak, Tinghu Zhang, Eric Fischer, Nathanael Gray, Lyn Jones

Cancer Res (2023) 83 (7_Supplement): 3426.

https://doi.org/10.1158/1538-7445.AM2023-3426

Published: 04 April 2023

View articletitled, Abstract 3426: Catalytic degraders effectively address kinase site mutations in EML-ALK oncogenic fusions

Journal Articles

Abstract 386: Metastatic models of resistance to next generation tyrosine kinase inhibitors (TKIs) in HER2-positive breast cancer (BC)

Fu-Tien Liao, Lanfang Qin, Martin J. Shea, Igor Bado, Yi-Hsuan Wu, Ling Wu, Yang Gao, Sarmistha Nanda, Tia Gordon, Chia Chia Liu, Xiang H.-F. Zhang, C. Kent Osborne, Mothaffar F. Rimawi, Jamunarani Veeraraghavan, Rachel Schiff

Cancer Res (2023) 83 (7_Supplement): 386.

https://doi.org/10.1158/1538-7445.AM2023-386

Published: 04 April 2023

View articletitled, Abstract 386: Metastatic models of resistance to next generation tyrosine kinase inhibitors (TKIs) in HER2-positive breast cancer (BC)

Journal Articles

Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer

Cancer Res (2022) 82 (12): 2281–2297.

https://doi.org/10.1158/0008-5472.CAN-21-3714

Published: 15 June 2022

View articletitled, Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract P4-08-01: Tumor suppressor PLK2 may serve as a biomarker in triple negative breast cancer for combinational therapy of PLK1 inhibitors with the standard-of-care chemotherapy

Yang Gao, Elena Kabotyanski, Deanna Acosta, Elizabeth Villegas, Thomas F Westbrook, Charles M Perou, Jeffrey M Rosen

Cancer Res (2020) 80 (4_Supplement): P4-08-01.

https://doi.org/10.1158/1538-7445.SABCS19-P4-08-01

Published: 15 February 2020

View articletitled, Abstract P4-08-01: Tumor suppressor PLK2 may serve as a biomarker in triple negative breast cancer for combinational therapy of PLK1 inhibitors with the standard-of-care chemotherapy

Journal Articles

Abstract 2216: A novel MRM-based mass spectrometry assay to quantify HMGB1

Dawn Zhaohui Chen, Weston R. Spivia, Yang Gao, Jennifer Van Eyk, Shreya Kanodia

Cancer Res (2017) 77 (13_Supplement): 2216.

https://doi.org/10.1158/1538-7445.AM2017-2216

Published: 01 July 2017

View articletitled, Abstract 2216: A novel MRM-based mass spectrometry assay to quantify HMGB1

Journal Articles

Abstract 1599: Elevated expression of ZEB1 upregulates VEGF expression and induces tumor angiogenesis in breast cancer

Qi Tong, Lingjia Liu, Lin Liang, Yang Gao, Shuang Yang

Cancer Res (2014) 74 (19_Supplement): 1599.

https://doi.org/10.1158/1538-7445.AM2014-1599

Published: 01 October 2014

View articletitled, Abstract 1599: Elevated expression of ZEB1 upregulates VEGF expression and induces tumor angiogenesis in breast cancer

Journal Articles

Abstract 2064: SF3B1 inhibitors sensitize head and neck squamous cell carcinoma to Bcl-xL inhibition by regulating Mcl-1 alternative splicing.

Yang Gao

Cancer Res (2013) 73 (8_Supplement): 2064.

https://doi.org/10.1158/1538-7445.AM2013-2064

Published: 15 April 2013

View articletitled, Abstract 2064: SF3B1 inhibitors sensitize head and neck squamous cell carcinoma to Bcl-xL inhibition by regulating Mcl-1 alternative splicing.

Journal Articles

Abstract 284: 17β-estradiol-induced expression of αEF1 confers tamoxifen resistance in breast cancer

Shaocong Guo, Fen Hu, Yang Gao, Tianhui Zhu, Shuang Yang

Cancer Res (2012) 72 (8_Supplement): 284.

https://doi.org/10.1158/1538-7445.AM2012-284

Published: 15 April 2012

View articletitled, Abstract 284: 17β-estradiol-induced expression of αEF1 confers tamoxifen resistance in breast cancer

Journal Articles

Abstract 4390: Role of uridine phosphorylase 2 in fluoropyrimidine activation and host toxicity

Amy J. Ziemba, Steven Brotman, Yang Gao, Michio Hirano, Giuseppe Pizzorno

Cancer Res (2011) 71 (8_Supplement): 4390.

https://doi.org/10.1158/1538-7445.AM2011-4390

Published: 15 April 2011

View articletitled, Abstract 4390: Role of uridine phosphorylase 2 in fluoropyrimidine activation and host toxicity

Journal Articles

Abstract 5526: Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2’-deoxycytidine

Jason A. Dubovsky, John J. Powers, Yang Gao, Luis F. Mariusso, Eduardo M. Sotomayor, Javier A. Pinilla-Ibarz

Cancer Res (2011) 71 (8_Supplement): 5526.

https://doi.org/10.1158/1538-7445.AM2011-5526

Published: 15 April 2011

View articletitled, Abstract 5526: Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2’-deoxycytidine

Journal Articles

Abstract 4771: Molecular, epigenetic, and phenotypic repolarization of human T lymphocytes using 5-aza-2′-deoxycytidine increases CD8 responsiveness and induces Th1 polarity

Jason A. Dubovsky, John J. Powers, Yang Gao, Javier A. Pinilla-Ibarz, Eduardo M. Sotomayor

Cancer Res (2010) 70 (8_Supplement): 4771.

https://doi.org/10.1158/1538-7445.AM10-4771

Published: 15 April 2010

View articletitled, Abstract 4771: Molecular, epigenetic, and phenotypic repolarization of human T lymphocytes using 5-aza-2′-deoxycytidine increases CD8 responsiveness and induces Th1 polarity

Journal Articles

Abstract 52: Overexpression of uridine phosphorylase 2 (UPP2) in tissues of uridine phosphorylase (UPP1) knock-out mice

Yang Gao, Amy Ziemba, Jennifer Turner, Giuseppe Pizzorno

Cancer Res (2010) 70 (8_Supplement): 52.

https://doi.org/10.1158/1538-7445.AM10-52

Published: 15 April 2010

View articletitled, Abstract 52: Overexpression of uridine phosphorylase 2 (UPP2) in tissues of uridine phosphorylase (UPP1) knock-out mice

Journal Articles

Inhibition of Tumor Metastasis by a Growth Factor Receptor Bound Protein 2 Src Homology 2 Domain–Binding Antagonist

Alessio Giubellino, Yang Gao, Sunmin Lee, Min-Jung Lee, James R. Vasselli, Sampath Medepalli, Jane B. Trepel, Terrence R. Burke, Jr., Donald P. Bottaro

Cancer Res (2007) 67 (13): 6012–6016.

https://doi.org/10.1158/0008-5472.CAN-07-0022

Published: 06 July 2007

View articletitled, Inhibition of Tumor Metastasis by a Growth Factor Receptor Bound Protein 2 Src Homology 2 Domain–Binding Antagonist

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract LB342: Potent Anti-Tumor Activity Demonstrated by Anti-AXL CAR T Cell Therapy and AXL-ADC in Lung Cancer and Breast Cancer Models

Abstract 3225: Profiling the DNA regulome to discover direct inhibitors of the brachyury transcription factor

Abstract 3426: Catalytic degraders effectively address kinase site mutations in EML-ALK oncogenic fusions

Abstract 386: Metastatic models of resistance to next generation tyrosine kinase inhibitors (TKIs) in HER2-positive breast cancer (BC)

Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer

Abstract P4-08-01: Tumor suppressor PLK2 may serve as a biomarker in triple negative breast cancer for combinational therapy of PLK1 inhibitors with the standard-of-care chemotherapy

Abstract 2216: A novel MRM-based mass spectrometry assay to quantify HMGB1

Abstract 1599: Elevated expression of ZEB1 upregulates VEGF expression and induces tumor angiogenesis in breast cancer

Abstract 2064: SF3B1 inhibitors sensitize head and neck squamous cell carcinoma to Bcl-xL inhibition by regulating Mcl-1 alternative splicing.

Abstract 284: 17β-estradiol-induced expression of αEF1 confers tamoxifen resistance in breast cancer

Abstract 4390: Role of uridine phosphorylase 2 in fluoropyrimidine activation and host toxicity

Abstract 5526: Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2’-deoxycytidine

Abstract 4771: Molecular, epigenetic, and phenotypic repolarization of human T lymphocytes using 5-aza-2′-deoxycytidine increases CD8 responsiveness and induces Th1 polarity

Abstract 52: Overexpression of uridine phosphorylase 2 (UPP2) in tissues of uridine phosphorylase (UPP1) knock-out mice

Inhibition of Tumor Metastasis by a Growth Factor Receptor Bound Protein 2 Src Homology 2 Domain–Binding Antagonist

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only